Ropes Wealth Advisors LLC Intellia Therapeutics, Inc. Transaction History

Ropes Wealth Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$58.27 - $118.99 $136,934 - $279,626	-2,350 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$60.88 - $161.91 $143,068 - $380,488	2,350 New	2,350 $380,000
Q1 2021 May 12, 2021	SELL	$46.59 - $83.68 $109,486 - $196,648	-2,350 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$18.83 - $63.53 $37,660 - $127,060	2,000 Added 571.43%	2,350 $128,000
Q3 2019 Nov 05, 2019	SELL	$13.07 - $18.51 $13,070 - $18,510	-1,000 Reduced 74.07%	350 $5,000
Q2 2019 Jul 31, 2019	BUY	$13.88 - $18.41 $13,880 - $18,410	1,000 Added 285.71%	1,350 $22,000
Q1 2019 Apr 15, 2019	BUY	$12.79 - $17.62 $4,476 - $6,167	350 New	350 $6,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.09B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Ropes Wealth Advisors LLC with notifications on news.